DrBicuspid

Synthetic sinus augmentation material fares well

A synthetic biphasic calcium phosphate material proved as reliable after a year as deproteinized cow bone for sinus augmentation in a clinical implant trial reported online May 11 in Clinical Implant ...
Becker's ASC

Intersect ENT gets CMS approval of coding for Propel sinus implant

Intersect ENT received CMS approval of a revised coding application for its Propel sinus implant, according to a Jan. 19 news release. Propel previously shared a billing code with Intersect ENT’s ...
DrBicuspid

Short vs. long implants: How do the results measure up?

How do the long-term results of short implants compare with those of long implants placed after maxillary sinus augmentation? To get a clear look at the risks and benefits of each, researchers ...
Nature

Maxillary Sinus Augmentation Techniques and Complications

Maxillary sinus augmentation remains a cornerstone intervention for addressing insufficient bone height in the posterior maxilla prior to dental implant placement. Techniques such as the lateral ...
Business Wire

EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Business Wire

Intersect ENT Announces Publication of Pooled Analysis of Steroid Releasing Implants in Patients Following Frontal Sinus Surgery

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a ...
Nature

Maxillary Sinus Floor Elevation And Augmentation

Maxillary sinus floor elevation and augmentation is a surgical procedure developed to increase bone volume in the atrophic posterior maxilla, thereby facilitating the precise placement of dental ...
MD&M East

Sinus Implant Launches During Start of Strong Allergy Season

Intersect ENT is launching its Sinuva Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery. The Menlo Park, CA-based company said nearly ...
The American Journal of Managed Care

Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis

Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
Nasdaq

Intersect ENT Announces Independent Analysis in UK Confirming Cost Effectiveness of PROPEL® Steroid Releasing Sinus Implant Following Sinus Surgery for Chronic Sinusitis

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the results of a ...
FierceBiotech

Intersect plugs positive drug-eluting sinus implant data

Intersect ENT showed it has another device to add to its line of sinus implants, touting positive data from a pilot study of its new steroid delivery implant to treat chronic sinusitis. The ...
Nasdaq

Intersect ENT Announces CMS Approval of Coding Application for PROPEL® Sinus Implant

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...